We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Immunotherapy for Prostate Cancer: Where We Are Headed.
- Authors
Schepisi, Giuseppe; Farolfi, Alberto; Conteduca, Vincenza; Martignano, Filippo; De Lisi, Delia; Ravaglia, Giorgia; Rossi, Lorena; Menna, Cecilia; Bellia, Salvatore Roberto; Barone, Domenico; Gunelli, Roberta; De Giorgi, Ugo
- Abstract
Prostate cancer is one of the most common malignant neoplasms in men worldwide, and is the fifth cause of cancer-related death. In recent years, a new generation of therapies have been approved for the management of metastatic disease. Moreover, the development of new immunotherapeutic drugs has become a novel frontier for the treatment of several tumor types; to date, numerous studies have investigated their potential activity, including in prostate cancer. In this article, we discuss the role of emerging immunotherapeutic drugs in prostate cancer patients.
- Subjects
PROSTATE cancer; CANCER-related mortality; CANCER treatment; METASTASIS; IMMUNOTHERAPY; PROSTATE cancer patients
- Publication
International Journal of Molecular Sciences, 2017, Vol 18, Issue 12, p2627
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms18122627